Latest News
- August 08, 2025International Publication of Phase II clinical Trial
- August 06, 2025Experience Agility-driven clinical trials with CBCC!
- July 23, 2025Discover the drive for swiftness in clinical research!
- July 16, 2025ANDA Approval Doxorubicin Hydrochloride Liposome
- July 14, 2025Accelerating Clinical Research!
Attending The 42nd Annual J. P. Morgan Healthcare Conference
Manoj Vyas (CEO – CBCC Global Research) will be attending The 42nd Annual J. P. Morgan Healthcare Conference, the largest and most informative healthcare investment symposium in the industry, during 8 – 11 January 2024, at San Francisco, CA.
For more information on this conference, please visit: https://lnkd.in/eZBPTdbM
For business appointments please email us at: manoj.vyas@cbcc.global
We will be attending below upcoming events:
1. The 42nd Annual J. P. Morgan Healthcare Conference (8 – 11 January 2024, San Francisco, California)
2. Bio Asia 2024 (26 – 28 February 2024, Hyderabad, India)
3. Immuno-Oncology 360 (27 – 29 February 2024, New York)
4. DCAT Week (18 – 21 March 2024, New York)
We will be glad to schedule an appointment with you to discuss your upcoming drug development plan and help you bring the treatment to market faster.
CBCC Global Research: CHANGING LIVES THROUGH HOPE AND INNOVATION